Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2794223
Reference Type
Journal Article
Title
PLASMA ESTRADIOL-17-BETA CONCENTRATIONS IN THE COW DURING INDUCED ESTRUS AND AFTER INJECTION OF ESTRADIOL-17-BETA BENZOATE AND ESTRADIOL-17-BETA CYPIONATE - A PRELIMINARY-STUDY
Author(s)
Vynckier, L; Debackere, M; Dekruif, A; Coryn, M
Year
1990
Is Peer Reviewed?
1
Journal
Journal of Veterinary Pharmacology and Therapeutics
ISSN:
0140-7783
EISSN:
1365-2885
Volume
13
Issue
1
Page Numbers
36-42
Language
English
PMID
2319634
DOI
10.1111/j.1365-2885.1990.tb00745.x
Web of Science Id
WOS:A1990CR51900006
Abstract
Plasma estradiol-17 beta concentrations were investigated in cows during induced estrus and after an intramuscular injection of 10 mg of estradiol-17 beta benzoate and estradiol-17 beta cypionate to determine a withdrawal period for both preparations. After the estradiol-17 beta benzoate injection, the plasma estradiol-17 beta concentration was higher than the physiological maximum of 24 pg/ml obtained during induced estrus for a period of 114 +/- 10 h (mean +/- SEM). For estradiol-17 beta cypionate the corresponding value was 170 +/- 17 h (mean +/- SEM). A withdrawal period of 7 days for the benzoate ester and of 10 days for estradiol-17 beta cypionate is therefore proposed. These results were confirmed by biopsies taken at the injection site 8 and 15 days after the injection of estradiol-17 beta benzoate and estradiol-17 beta cypionate, respectively. In these biopsies no residues of estradiol-17 beta nor of its esters could be detected.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity